Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
5
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
clinical trials
fda
avexis
bristol-myers squibb
cancer
cancer immunotherapy
celgene
drugs
geoffrey porges
immunotherapy
intercept pharmaceuticals
medical device
nonalcoholic steatohepatitis
What
disease
5
×
drug
roundup
bio
liver
nash
news
race
according
advanced
akcea
alnylam’s
alzheimer's
american
approval
approved
ash
bad
bff
big
biotech
blood
brain
cancer
case
cases
centers
cigarettes
companies
conference
control
country
deals
deaths
devoted
diego
digital
doses
easl
electronic
Language
unset
Current search:
national
×
disease
×
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
ASH 2018: Three Up, Two Down As The Big Blood Disease Meeting Rolls On
